Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Pulmonary Disease, Chronic Obstructive 1Lung Neoplasms 1Disease 1Diabetes Mellitus, Type 2 1

Interventions

Blood Specimen Collection 32Surveys and Questionnaires 24Radiotherapy 12Gene Expression Profiling 12Drug Therapy 12Surgical Procedures, Operative 11Bronchoscopy 10Magnetic Resonance Spectroscopy 9Immunotherapy 9Immunohistochemistry 9Tomography, X-Ray Computed 8Specimen Handling 8Observation 8Amplified Fragment Length Polymorphism Analysis 8Polymerase Chain Reaction 7pembrolizumab 6Psychiatric Rehabilitation 6Interviews as Topic 6Carboplatin 6Thoracic Surgery, Video-Assisted 5Reverse Transcriptase Polymerase Chain Reaction 5Microarray Analysis 5Liquid Biopsy 5Chemoradiotherapy 5Bevacizumab 5durvalumab 4Therapeutics 4Paclitaxel 4Nivolumab 4Ipilimumab 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Lung Neoplasms × Sodium-Glucose Transporter 2 Inhibitors × Clear all
NCT07332156 2026-01-14

Lung Cancer Risk in Type 2 Diabetes With COPD: SGLT2 Inhibitors vs. Sulfonylureas

Samsung Medical Center

Completed
21,692 enrolled
Thoracic

Diabetes Mellitus, Type 2, Disease, Lung Neoplasms, Pulmonary Disease, Chronic Obstructive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡